Cursos

Actividades Académicas
Atrás

XIV International School of Pharmacology «Teófilo Hernando». New Therapeutic Targets in Brain Disease

Información General

Programa curso

Becarios

Becas ConcedidasBecas en Lista de Espera

Matrícula

procedimiento para solicitar matricula online
Código
62IH
Horas
30
Fecha
20 Jul 2015
24 Jul 2015
Precio
130 € Tarifa A
Tipo
Escuela
Temática
Ciencias y Tecnología
ECTS
1

Sede donde se gestiona

Santander

Lugar de impartición

Santander - Península de la Magdalena (Rector Ernest Lluch)

Dirección

Antonio G. García
Professor of Pharmacology
Teófilo Hernando's Institute for Drug Discovery
Medical School, Autonomous University of Madrid, Spain


Michael Duchen
Professor of Physiology
Department of Cell and Development Biology
University College London, UK


Secretaría

Luis Gandía
Professor of Pharmacology
Teófilo Hernando's Institute for Drug Discovery
Medical School, Autonomous University of Madrid, Spain


COLABORACIÓN


COLABORACIÓN


COLABORACIÓN

Descripción de la actividad

The Teófilo Hernando’s School of Pharmacology (THSP)

was initiated in 1996, in the frame of the summer courses

of the UIMP. At that time, Rector José Luis García Delgado

invited professor Antonio G. García (Autonomous University

of Madrid) to organize this School. The courses are held at

the magnificent Palace of la Magdalena, located on top of

a hill at the Peninsula of La Magdalena.

The format of a UIMP’s School «Escuela» is based in

the critical analysis in the frontier of knowledge of a

given scientific topic, along a week (Monday to Friday) by

scientists and students of all over the world. Emphasis

is always made in drug discovery and development as

well in basic research that illuminate on the identification

of new biological drug targets for treating disease. The

THSP was named after Teófilo Hernando, a Spanish

MD/PhD pharmacologist who was trained under

Oswald Schmiedeberg at Strasbourg, the first formal

Pharmacology School where many pharmacologists

were trained at the beginning of the XX century and then

developed the subject of basic and clinical pharmacology

all over the world. Teófilo Hernando introduced

pharmacology as an independent teaching and science

subject at the Central University of Madrid, along the fi rst

four decades of the XX century. He trained numerous other

disciples that extended the subject to many other Spanish

universities along the XX century.

Since 1996, 13 editions of the THSP have been held. Over

100 internationally recognized scientist professors and

over 500 students have since then attended the THSP.

Participantes

DIRECCIÓN

Michael Duchen
Professor of Physiology
Department of Cell and Development Biology
University College London, UK

Antonio G. García
Professor of Pharmacology
Teófilo Hernando's Institute for Drug Discovery
Medical School, Autonomous University of Madrid, Spain

SECRETARÍA

Luis Gandía
Professor of Pharmacology
Teófilo Hernando's Institute for Drug Discovery
Medical School, Autonomous University of Madrid, Spain

PARTICIPANTES

José Manuel Bartolomé
Janssen-Cilag, Toledo, Spain

Clémence Cheignon
Young Researcher

Enrique Cobos
University of Granada, Spain

Amandine Conte-Daban
Young Researcher

Manuel Criado
Neuroscience Institute Miguel Hernández University, Elche, Spain

Cristóbal de los Ríos Salgado
Young Researcher

Melisa del Barrio Redondo
Young Researcher

Javier Fernández Gadea
Janssen-Cilag, Toledo, Spain

Santiago García Martín
Young Researcher

Javier García Sancho
Médical School University of Valladolid, Spain

John Kemp
Janssen-Cilag; Beerse, Belgium

Rafael León
Autonomous University of Madrid, Spain

Juan Lerma
Instituto de Neurociencias; CSIC-UMH, Alicante, Spain

Tristan McKay
St. George University of London, London, UK

Iago Méndez López
Young Researcher

Ángeles Montilla García
Young Researcher

James Putney
National Institute of Environmental Health Sciences-NIH, North Carolina, USA

Marija Sajic
University College London, UK

Cristina Sánchez Fernández
Young Researcher

Paul Schumacker
Northwestern University, Chicago, USA

María Stoessel
Young Researcher

Miguel Ángel Tejada Giráldez
Young Researcher

Laura Wagstaff
Young Researcher

Programa

Lunes, 20 Julio 2015

10:00
Inauguration
Antonio G. García
Michael Duchen
10:30
Inaugural Lecture: Discovery and impact of capacitative calcium entry in health and disease
James Putney
12:30
A new fluorescent probe to monitor calcium signals in vitro and in vivo
Javier García Sancho
15:00
Young Research Communications-I:
Ageing, oxidative stress, neuroinflammation and Alzheimer's disease
Alzheimer's disease: specific Cu(II) chelators to inhibit the deleterious effects of Amyloid-ß-Cu(II)
Amandine Conte-Daban
Metal-catalyzed oxidation of beta-amyloid peptide and ROS production
Clémence Cheignon
Impact of cooper on amyloid-ß aggregation and ROS production linked to Alzheimer's disease
Melisa del Barrio Redondo
Coordinator
Rafael León
Paul Schumacker

Martes, 21 Julio 2015

10:00
Mitochondrial bioenergetics in health and disease
Michael Duchen
12:30
Nicotinic receptors as targets for neuroprotection
Manuel Criado
15:00
Young Research Communications-II:
Nicotinic receptors and calcium channels as therapeutic targets for brain disease
Augmented Ca2+ signaling and catecholamine release from chromaffin cells of diabetic and hypertensive rats
Iago Méndez López
TRP channels: a new target for pain relief
Santiago García Martín
Okadaic acid fragments protects against okadaic acid-induced neurodegeneration
Cristóbal de los Ríos Salgado
Coordinator
Luis Gandía

Miércoles, 22 Julio 2015

10:00
Pathways of differentiation for neurones from stem cells and their use for disease modelling
Tristan McKay
12:00
Kainate receptors in health and disease
Juan Lerma
15:00
Young Research Communications-III:
Nerve injury and nerve repairing
Peripheral nerve regeneration through hollow, enriched and chambered chitosan-based nerve guidance conduits
María Stoessel
The role of c-Jun in Schwann cells following long term injury
Laura Wagstaff
Coordinator
Marija Sajic

Jueves, 23 Julio 2015

10:00
ROS signalling
Paul Schumacker
12:30
Amyotrophic lateral sclerosis: more than just a motoneuron disease
Antonio G. García
15:00
Young Research Communications-IV:
Pain: new targets and drugs
Differential modulation of µ-opioid analgesia and constipation by ¿ 1 receptors
Cristina Sánchez Fernández
Immune-mediated opioid analgesia unmasked by sigma-1 receptor antagonism: studies on inflammatory pain
Miguel Ángel Tejada Giráldez
Beside-to-bench evaluation of pain: grip strength as an indicator of pain induced by inflammatory arthritis in the mouse
Ángeles Montilla García
Coordinator
Enrique Cobos

Viernes, 24 Julio 2015

10:00
Open innovation in Pharma R&D: not sharing is not an option anymore
Javier Fernández Gadea
10:45
Novel positive allosteric modulators of the metabotropic glutamate receptor 5 as potential antipsychotic agents
José Manuel Bartolomé
11:30
Closing lecture: Perspectives in drug development for Alzheimer's disease
John Kemp
13:00
Closing ceremony
Antonio G. García
Michael Duchen

Sin fecha definida

A new fluorescent probe to monitor calcium signals in vitro and in vivo
Young Research Communications-I:
Ageing, oxidative stress, neuroinflammation and Alzheimer's disease
Mitochondrial bioenergetics in health and disease
Nicotinic receptors as targets for neuroprotection
Young Research Communications-II:
Nicotinic receptors and calcium channels as therapeutic targets for brain disease
Pathways of differentiation for neurones from stem cells and their use for disease modelling
Kainate receptors in health and disease
Young Research Communications-III:
Nerve injury and nerve repairing
ROS signalling
Amyotrophic lateral sclerosis: more than just a motoneuron disease
Young Research Communications-IV:
Pain: new targets and drugs
Open innovation in Pharma R&D: not sharing is not an option anymore
Closing lecture: Perspectives in drug development for Alzheimer's disease
Closing ceremony
Inaugural Lecture: Discovery and impact of capacitative calcium entry in health and disease
Inauguration
Novel positive allosteric modulators of the metabotropic glutamate receptor 5 as potential antipsychotic agents